Search
screening for cardiovascular disease
Also see cardiovascular risk factor
Indications:
- screening for AAA*, PAD*, high BP* reduces mortality [2]
* screening for abdominal aortic aneurysm (AAA)
* screening for peripheral arterial disease (PAD)
* screening for hypertension (high BP)
Contraindications:
- screening general population for cardiovascular risk factors does not improve 10 year risk of ischemic heart disease, stroke, or overall mortality [1]
- screening low risk patients with electrocardiogram (ECG) [3]*
- no benefit for screening men age 65-74 years [4]
* insufficent evidence to recommend for or against screening intermediate or high-risk patients with ECG [3]
Related
cardiovascular disease (CVD)
cardiovascular risk factor
Specific
screening for hypertension
screening for ischemic heart disease
General
screening
References
- Jorgensen T et al
Effect of screening and lifestyle counselling on incidence of
ischaemic heart disease in general population: Inter99
randomised trial.
BMJ 2014;348:g3617
PMID: 24912589
http://www.bmj.com/content/348/bmj.g3617
- Gotzsche P
General health checks don't work
BMJ 2014;348:g3680
PMID: 24912801
http://www.bmj.com/content/348/bmj.g3680
- Busko M
'Triple' Screening for AAA, PAD, High BP Reduces Mortality
Medscape - Aug 31, 2017.
Coverage from the European Society of Cardiology (ESC) Congress
2017
http://www.medscape.com/viewarticle/885058
- Bhatia RS, Dorian P.
Screening for Cardiovascular Disease Risk With Electrocardiography.
JAMA Intern Med. Published online June 12, 2018
Bhatia RS, Dorian P.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2683617
- US Preventive Services Task Force
Screening for Cardiovascular Disease Risk With Electrocardiography.
US Preventive Services Task Force Recommendation Statement.
JAMA. 2018;319(22):2308-2314
PMID: 29896632
https://jamanetwork.com/journals/jama/fullarticle/2684613
- Jonas DE, Reddy S, Middleton JC et al
Screening for Cardiovascular Disease Risk With Resting or
Exercise Electrocardiography. Evidence Report and Systematic
Review for the US Preventive Services Task Force.
JAMA. 2018;319(22):2315-2328
PMID: 29896633
https://jamanetwork.com/journals/jama/fullarticle/2684614
- Myerburg RJ
The Screening ECG and Cardiac Risks.
JAMA. 2018;319(22):2277-2279.
PMID: 29896615
https://jamanetwork.com/journals/jama/fullarticle/2684593
- Lindholt JS et al.
Five-year outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial.
N Engl J Med 2022 Aug 27; [e-pub]
PMID: 36027560
https://www.nejm.org/doi/10.1056/NEJMoa2208681
Components
screening for abdominal aortic aneurysm (AAA)
screening for hypertension
screening for peripheral arterial disease